December 2013

Bone Marrow Transplantation (BMT) and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

Condition:   Kidney Transplantation
Interventions:   Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)

Genetic Characterization of Movement Disorders and Dementias

Conditions:   Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
Intervention:  
Sponsor:   National Institute on Aging (NIA)
Recruiting - verified November 15, 2016

Study of Electrical Impedance Myography (EIM) in ALS

Conditions:   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Charcot-Marie-Tooth Disease;   Multiple Sclerosis
Intervention:   Device: Electrical impedance myography (EIM)
Sponsor:   Skulpt, Inc.
Completed - verified May 2016